Trevena Inc (TRVN)
0.44
+0.02
(+6.02%)
USD |
NASDAQ |
May 07, 10:03
Trevena Total Assets (Quarterly): 40.60M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 40.60M |
| September 30, 2023 | 45.13M |
| June 30, 2023 | 38.86M |
| March 31, 2023 | 38.29M |
| December 31, 2022 | 48.68M |
| September 30, 2022 | 51.02M |
| June 30, 2022 | 64.80M |
| March 31, 2022 | 64.42M |
| December 31, 2021 | 80.12M |
| September 30, 2021 | 91.65M |
| June 30, 2021 | 112.20M |
| March 31, 2021 | 118.50M |
| December 31, 2020 | 127.74M |
| September 30, 2020 | 122.56M |
| June 30, 2020 | 66.32M |
| March 31, 2020 | 39.05M |
| December 31, 2019 | 46.99M |
| September 30, 2019 | 56.77M |
| June 30, 2019 | 65.18M |
| March 31, 2019 | 71.89M |
| December 31, 2018 | 66.78M |
| September 30, 2018 | 76.11M |
| Date | Value |
|---|---|
| June 30, 2018 | 72.33M |
| March 31, 2018 | 68.64M |
| December 31, 2017 | 72.72M |
| September 30, 2017 | 84.24M |
| June 30, 2017 | 92.01M |
| March 31, 2017 | 103.14M |
| December 31, 2016 | 114.65M |
| September 30, 2016 | 122.13M |
| June 30, 2016 | 148.57M |
| March 31, 2016 | 166.91M |
| December 31, 2015 | 175.35M |
| September 30, 2015 | 170.67M |
| June 30, 2015 | 107.99M |
| March 31, 2015 | 103.20M |
| December 31, 2014 | 108.24M |
| September 30, 2014 | 73.96M |
| June 30, 2014 | 84.69M |
| March 31, 2014 | 95.16M |
| December 31, 2013 | 42.39M |
| September 30, 2013 | 50.45M |
| June 30, 2013 | 56.45M |
| December 31, 2012 | 8.088M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
38.29M
Minimum
Mar 2023
127.74M
Maximum
Dec 2020
69.42M
Average
64.42M
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
| Oragenics Inc | 4.966M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.26M |
| Shareholders Equity (Quarterly) | -7.657M |
| Debt to Equity Ratio | -4.024 |
| Current Ratio | 4.660 |
| Net Debt Paydown Yield | -27.68% |